ChEMBL

We have a position in the group in the area of ion-channel structural pharmacology - mapping known ion-channel modulators to sequences and binding sites. This will be in partnership with Pfizer, and the role will involve time spent both at the EBI and at Pfizer's labs in the Cambridge UK area - so a great opportunity to pick up some industrial experience.

If you are interested, please get in touch by December 15th 2012, when we will shortlist candidates for interview.